Stay updated on Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial page.

Latest updates to the Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial page
- Check6 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 appears to be an administrative update, and the removal of the prior funding-status notice (Revision: v3.4.1) does not affect trial details or patient-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedAdded a site-wide notice about government funding impacts on information currency and facility operations. Updated the page revision to v3.4.1.SummaryDifference0.4%

- Check48 days agoChange DetectedThe updates include adding a glossary toggle and new metadata entries such as 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', while removing the older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page shows a revision tag updated from v3.3.3 to v3.3.4, indicating a frontend version update.SummaryDifference0.1%

- Check84 days agoChange DetectedAdded a dedicated Locations section with Georgia as a site. Removed the separate Georgia Locations entry and updated the page revision to v3.3.3.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial page.